Profile
Seonghwan Lee has current jobs as a Director at SV Investment Corp and as a Board Member at Orange Grove Bio LLC.
He has an undergraduate degree from Yonsei University and an MBA from Harvard Business School.
Seonghwan Lee active positions
| Companies | Position | Start |
|---|---|---|
| SV Investment Corp/US/ | Private Equity Investor | 2020-02-29 |
Orange Grove Bio LLC
 Orange Grove Bio LLC Financial ConglomeratesFinance Orange Grove Bio LLC is a preclinical biotech company that partners with universities and entrepreneurs to develop innovative treatments for important diseases, particularly cancer and immune disorders. The company is based in Cincinnati, OH. The company fosters strong relationships with entrepreneurs and technology transfer offices outside of the traditional medical technology hubs. Orange Grove Bio's team possesses more than one hundred years of drug development and company creation experience, allowing it to build and finance innovative programs from the research and development stage to clinical trials. The company was founded by Marc Appel. Marc Appel has been the CEO since incorporation. | Director/Board Member | 2022-10-31 |
Training of Seonghwan Lee
| Harvard Business School | Masters Business Admin |
| Yonsei University | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 2 |
|---|---|
| SV Investment Corp/US/ | Finance |
Orange Grove Bio LLC
Orange Grove Bio LLC Financial ConglomeratesFinance Orange Grove Bio LLC is a preclinical biotech company that partners with universities and entrepreneurs to develop innovative treatments for important diseases, particularly cancer and immune disorders. The company is based in Cincinnati, OH. The company fosters strong relationships with entrepreneurs and technology transfer offices outside of the traditional medical technology hubs. Orange Grove Bio's team possesses more than one hundred years of drug development and company creation experience, allowing it to build and finance innovative programs from the research and development stage to clinical trials. The company was founded by Marc Appel. Marc Appel has been the CEO since incorporation. | Finance |
- Stock Market
- Insiders
- Seonghwan Lee
